nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Doxorubicin—Epirubicin—sarcoma	0.0169	0.519	CbGdCrCtD
Emtricitabine—DCK—Epirubicin—Doxorubicin—sarcoma	0.0157	0.481	CbGdCrCtD
Emtricitabine—DCK—myometrium—sarcoma	0.00539	0.125	CbGeAlD
Emtricitabine—DCK—embryo—sarcoma	0.00519	0.12	CbGeAlD
Emtricitabine—DCK—seminal vesicle—sarcoma	0.00487	0.113	CbGeAlD
Emtricitabine—DCK—hematopoietic system—sarcoma	0.00463	0.107	CbGeAlD
Emtricitabine—DCK—cardiac atrium—sarcoma	0.00352	0.0815	CbGeAlD
Emtricitabine—DCK—uterus—sarcoma	0.0035	0.0811	CbGeAlD
Emtricitabine—DCK—lymphoid tissue—sarcoma	0.00326	0.0755	CbGeAlD
Emtricitabine—DCK—tendon—sarcoma	0.00307	0.071	CbGeAlD
Emtricitabine—DCK—bone marrow—sarcoma	0.00297	0.0688	CbGeAlD
Emtricitabine—Urinary tract disorder—Etoposide—sarcoma	0.00262	0.00284	CcSEcCtD
Emtricitabine—Infection—Thiotepa—sarcoma	0.00261	0.00282	CcSEcCtD
Emtricitabine—Urethral disorder—Etoposide—sarcoma	0.0026	0.00282	CcSEcCtD
Emtricitabine—Infection—Dactinomycin—sarcoma	0.00259	0.0028	CcSEcCtD
Emtricitabine—Nervous system disorder—Thiotepa—sarcoma	0.00258	0.00279	CcSEcCtD
Emtricitabine—Neuropathy—Doxorubicin—sarcoma	0.00258	0.00279	CcSEcCtD
Emtricitabine—Thrombocytopenia—Thiotepa—sarcoma	0.00257	0.00278	CcSEcCtD
Emtricitabine—Anaemia—Mitoxantrone—sarcoma	0.00257	0.00278	CcSEcCtD
Emtricitabine—Thrombocytopenia—Dactinomycin—sarcoma	0.00255	0.00276	CcSEcCtD
Emtricitabine—Skin disorder—Thiotepa—sarcoma	0.00255	0.00276	CcSEcCtD
Emtricitabine—DCK—testis—sarcoma	0.00254	0.0588	CbGeAlD
Emtricitabine—Rash maculo-papular—Doxorubicin—sarcoma	0.00249	0.0027	CcSEcCtD
Emtricitabine—Myalgia—Vincristine—sarcoma	0.00243	0.00263	CcSEcCtD
Emtricitabine—Cough—Mitoxantrone—sarcoma	0.00243	0.00262	CcSEcCtD
Emtricitabine—DCK—liver—sarcoma	0.0024	0.0556	CbGeAlD
Emtricitabine—Immune system disorder—Etoposide—sarcoma	0.0024	0.0026	CcSEcCtD
Emtricitabine—Mediastinal disorder—Etoposide—sarcoma	0.00239	0.00259	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00239	0.00259	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00238	0.00257	CcSEcCtD
Emtricitabine—Arthralgia—Mitoxantrone—sarcoma	0.00237	0.00256	CcSEcCtD
Emtricitabine—Myalgia—Mitoxantrone—sarcoma	0.00237	0.00256	CcSEcCtD
Emtricitabine—Paraesthesia—Thiotepa—sarcoma	0.00236	0.00255	CcSEcCtD
Emtricitabine—Anxiety—Mitoxantrone—sarcoma	0.00236	0.00255	CcSEcCtD
Emtricitabine—Renal failure acute—Epirubicin—sarcoma	0.00233	0.00252	CcSEcCtD
Emtricitabine—Infection—Vincristine—sarcoma	0.00231	0.0025	CcSEcCtD
Emtricitabine—Dyspepsia—Thiotepa—sarcoma	0.00231	0.0025	CcSEcCtD
Emtricitabine—Nervous system disorder—Vincristine—sarcoma	0.00228	0.00247	CcSEcCtD
Emtricitabine—Thrombocytopenia—Vincristine—sarcoma	0.00228	0.00247	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00227	0.00245	CcSEcCtD
Emtricitabine—Fatigue—Thiotepa—sarcoma	0.00226	0.00245	CcSEcCtD
Emtricitabine—Renal impairment—Epirubicin—sarcoma	0.00226	0.00245	CcSEcCtD
Emtricitabine—Infection—Mitoxantrone—sarcoma	0.00225	0.00244	CcSEcCtD
Emtricitabine—Dermatitis bullous—Epirubicin—sarcoma	0.00225	0.00244	CcSEcCtD
Emtricitabine—Fatigue—Dactinomycin—sarcoma	0.00225	0.00243	CcSEcCtD
Emtricitabine—Pain—Thiotepa—sarcoma	0.00225	0.00243	CcSEcCtD
Emtricitabine—Back pain—Etoposide—sarcoma	0.00224	0.00242	CcSEcCtD
Emtricitabine—Pain—Dactinomycin—sarcoma	0.00223	0.00241	CcSEcCtD
Emtricitabine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00222	0.0024	CcSEcCtD
Emtricitabine—Skin disorder—Mitoxantrone—sarcoma	0.0022	0.00238	CcSEcCtD
Emtricitabine—Renal failure acute—Doxorubicin—sarcoma	0.00216	0.00233	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Thiotepa—sarcoma	0.00215	0.00232	CcSEcCtD
Emtricitabine—Anaemia—Etoposide—sarcoma	0.00214	0.00231	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00213	0.00231	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00212	0.0023	CcSEcCtD
Emtricitabine—Insomnia—Vincristine—sarcoma	0.00211	0.00228	CcSEcCtD
Emtricitabine—Renal impairment—Doxorubicin—sarcoma	0.00209	0.00226	CcSEcCtD
Emtricitabine—Paraesthesia—Vincristine—sarcoma	0.00209	0.00226	CcSEcCtD
Emtricitabine—Urticaria—Thiotepa—sarcoma	0.00209	0.00226	CcSEcCtD
Emtricitabine—Dermatitis bullous—Doxorubicin—sarcoma	0.00208	0.00225	CcSEcCtD
Emtricitabine—Body temperature increased—Thiotepa—sarcoma	0.00208	0.00225	CcSEcCtD
Emtricitabine—Abdominal pain—Thiotepa—sarcoma	0.00208	0.00225	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00207	0.00224	CcSEcCtD
Emtricitabine—Body temperature increased—Dactinomycin—sarcoma	0.00206	0.00223	CcSEcCtD
Emtricitabine—Abdominal pain—Dactinomycin—sarcoma	0.00206	0.00223	CcSEcCtD
Emtricitabine—Paraesthesia—Mitoxantrone—sarcoma	0.00204	0.0022	CcSEcCtD
Emtricitabine—Dyspnoea—Mitoxantrone—sarcoma	0.00202	0.00219	CcSEcCtD
Emtricitabine—Cough—Etoposide—sarcoma	0.00202	0.00218	CcSEcCtD
Emtricitabine—Blood creatinine increased—Epirubicin—sarcoma	0.00202	0.00218	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Vincristine—sarcoma	0.00201	0.00218	CcSEcCtD
Emtricitabine—Fatigue—Vincristine—sarcoma	0.00201	0.00217	CcSEcCtD
Emtricitabine—Dyspepsia—Mitoxantrone—sarcoma	0.002	0.00216	CcSEcCtD
Emtricitabine—Pain—Vincristine—sarcoma	0.00199	0.00216	CcSEcCtD
Emtricitabine—Hypokalaemia—Epirubicin—sarcoma	0.00196	0.00212	CcSEcCtD
Emtricitabine—Fatigue—Mitoxantrone—sarcoma	0.00196	0.00212	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00195	0.00211	CcSEcCtD
Emtricitabine—Breast disorder—Epirubicin—sarcoma	0.00194	0.0021	CcSEcCtD
Emtricitabine—Pain—Mitoxantrone—sarcoma	0.00194	0.0021	CcSEcCtD
Emtricitabine—Hypersensitivity—Thiotepa—sarcoma	0.00194	0.00209	CcSEcCtD
Emtricitabine—Nasopharyngitis—Epirubicin—sarcoma	0.00192	0.00208	CcSEcCtD
Emtricitabine—Hypersensitivity—Dactinomycin—sarcoma	0.00192	0.00208	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Vincristine—sarcoma	0.0019	0.00206	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.0019	0.00205	CcSEcCtD
Emtricitabine—Muscular weakness—Epirubicin—sarcoma	0.0019	0.00205	CcSEcCtD
Emtricitabine—Asthenia—Thiotepa—sarcoma	0.00188	0.00204	CcSEcCtD
Emtricitabine—Infection—Etoposide—sarcoma	0.00187	0.00203	CcSEcCtD
Emtricitabine—Asthenia—Dactinomycin—sarcoma	0.00187	0.00202	CcSEcCtD
Emtricitabine—Blood creatinine increased—Doxorubicin—sarcoma	0.00187	0.00202	CcSEcCtD
Emtricitabine—Pruritus—Thiotepa—sarcoma	0.00186	0.00201	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00185	0.00201	CcSEcCtD
Emtricitabine—Thrombocytopenia—Etoposide—sarcoma	0.00185	0.002	CcSEcCtD
Emtricitabine—Body temperature increased—Vincristine—sarcoma	0.00184	0.00199	CcSEcCtD
Emtricitabine—Abdominal pain—Vincristine—sarcoma	0.00184	0.00199	CcSEcCtD
Emtricitabine—DCK—lymph node—sarcoma	0.00184	0.0426	CbGeAlD
Emtricitabine—Skin disorder—Etoposide—sarcoma	0.00183	0.00198	CcSEcCtD
Emtricitabine—Pancreatitis—Epirubicin—sarcoma	0.00182	0.00197	CcSEcCtD
Emtricitabine—Hypokalaemia—Doxorubicin—sarcoma	0.00181	0.00196	CcSEcCtD
Emtricitabine—Urticaria—Mitoxantrone—sarcoma	0.0018	0.00195	CcSEcCtD
Emtricitabine—Breast disorder—Doxorubicin—sarcoma	0.0018	0.00195	CcSEcCtD
Emtricitabine—Diarrhoea—Thiotepa—sarcoma	0.0018	0.00194	CcSEcCtD
Emtricitabine—Abdominal pain—Mitoxantrone—sarcoma	0.00179	0.00194	CcSEcCtD
Emtricitabine—Body temperature increased—Mitoxantrone—sarcoma	0.00179	0.00194	CcSEcCtD
Emtricitabine—Diarrhoea—Dactinomycin—sarcoma	0.00178	0.00193	CcSEcCtD
Emtricitabine—Nasopharyngitis—Doxorubicin—sarcoma	0.00178	0.00193	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00176	0.0019	CcSEcCtD
Emtricitabine—Muscular weakness—Doxorubicin—sarcoma	0.00176	0.0019	CcSEcCtD
Emtricitabine—Neutropenia—Epirubicin—sarcoma	0.00174	0.00188	CcSEcCtD
Emtricitabine—Dizziness—Thiotepa—sarcoma	0.00174	0.00188	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Epirubicin—sarcoma	0.00173	0.00187	CcSEcCtD
Emtricitabine—Hypersensitivity—Vincristine—sarcoma	0.00172	0.00186	CcSEcCtD
Emtricitabine—Paraesthesia—Etoposide—sarcoma	0.00169	0.00183	CcSEcCtD
Emtricitabine—Pancreatitis—Doxorubicin—sarcoma	0.00169	0.00183	CcSEcCtD
Emtricitabine—Weight decreased—Epirubicin—sarcoma	0.00168	0.00182	CcSEcCtD
Emtricitabine—Dyspnoea—Etoposide—sarcoma	0.00168	0.00182	CcSEcCtD
Emtricitabine—Hyperglycaemia—Epirubicin—sarcoma	0.00168	0.00182	CcSEcCtD
Emtricitabine—Hypersensitivity—Mitoxantrone—sarcoma	0.00167	0.00181	CcSEcCtD
Emtricitabine—Asthenia—Vincristine—sarcoma	0.00167	0.00181	CcSEcCtD
Emtricitabine—Vomiting—Thiotepa—sarcoma	0.00167	0.00181	CcSEcCtD
Emtricitabine—Pneumonia—Epirubicin—sarcoma	0.00167	0.0018	CcSEcCtD
Emtricitabine—Infestation NOS—Epirubicin—sarcoma	0.00166	0.00179	CcSEcCtD
Emtricitabine—Infestation—Epirubicin—sarcoma	0.00166	0.00179	CcSEcCtD
Emtricitabine—Vomiting—Dactinomycin—sarcoma	0.00166	0.00179	CcSEcCtD
Emtricitabine—Rash—Thiotepa—sarcoma	0.00166	0.00179	CcSEcCtD
Emtricitabine—Dermatitis—Thiotepa—sarcoma	0.00165	0.00179	CcSEcCtD
Emtricitabine—Headache—Thiotepa—sarcoma	0.00165	0.00178	CcSEcCtD
Emtricitabine—Rash—Dactinomycin—sarcoma	0.00164	0.00178	CcSEcCtD
Emtricitabine—Renal failure—Epirubicin—sarcoma	0.00163	0.00176	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Etoposide—sarcoma	0.00163	0.00176	CcSEcCtD
Emtricitabine—Asthenia—Mitoxantrone—sarcoma	0.00163	0.00176	CcSEcCtD
Emtricitabine—Fatigue—Etoposide—sarcoma	0.00163	0.00176	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Epirubicin—sarcoma	0.00163	0.00176	CcSEcCtD
Emtricitabine—Pain—Etoposide—sarcoma	0.00161	0.00175	CcSEcCtD
Emtricitabine—Urinary tract infection—Epirubicin—sarcoma	0.00161	0.00174	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—sarcoma	0.00161	0.00174	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.0016	0.00173	CcSEcCtD
Emtricitabine—Diarrhoea—Vincristine—sarcoma	0.00159	0.00172	CcSEcCtD
Emtricitabine—Haematuria—Epirubicin—sarcoma	0.00158	0.00171	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Epirubicin—sarcoma	0.00157	0.0017	CcSEcCtD
Emtricitabine—Nausea—Thiotepa—sarcoma	0.00156	0.00169	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—sarcoma	0.00156	0.00168	CcSEcCtD
Emtricitabine—Sinusitis—Epirubicin—sarcoma	0.00156	0.00168	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—sarcoma	0.00155	0.00168	CcSEcCtD
Emtricitabine—Diarrhoea—Mitoxantrone—sarcoma	0.00155	0.00168	CcSEcCtD
Emtricitabine—Nausea—Dactinomycin—sarcoma	0.00155	0.00168	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—sarcoma	0.00154	0.00167	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Etoposide—sarcoma	0.00154	0.00167	CcSEcCtD
Emtricitabine—Dizziness—Vincristine—sarcoma	0.00154	0.00167	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—sarcoma	0.00153	0.00166	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—sarcoma	0.00153	0.00166	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—sarcoma	0.00151	0.00163	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—sarcoma	0.0015	0.00163	CcSEcCtD
Emtricitabine—Urticaria—Etoposide—sarcoma	0.0015	0.00162	CcSEcCtD
Emtricitabine—Rhinitis—Epirubicin—sarcoma	0.00149	0.00161	CcSEcCtD
Emtricitabine—Abdominal pain—Etoposide—sarcoma	0.00149	0.00161	CcSEcCtD
Emtricitabine—Body temperature increased—Etoposide—sarcoma	0.00149	0.00161	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—sarcoma	0.00149	0.00161	CcSEcCtD
Emtricitabine—Hepatitis—Epirubicin—sarcoma	0.00149	0.00161	CcSEcCtD
Emtricitabine—Vomiting—Vincristine—sarcoma	0.00148	0.0016	CcSEcCtD
Emtricitabine—Pharyngitis—Epirubicin—sarcoma	0.00148	0.0016	CcSEcCtD
Emtricitabine—Urinary tract disorder—Epirubicin—sarcoma	0.00147	0.00159	CcSEcCtD
Emtricitabine—Rash—Vincristine—sarcoma	0.00147	0.00159	CcSEcCtD
Emtricitabine—Dermatitis—Vincristine—sarcoma	0.00147	0.00159	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—sarcoma	0.00146	0.00158	CcSEcCtD
Emtricitabine—Connective tissue disorder—Epirubicin—sarcoma	0.00146	0.00158	CcSEcCtD
Emtricitabine—Urethral disorder—Epirubicin—sarcoma	0.00146	0.00158	CcSEcCtD
Emtricitabine—Headache—Vincristine—sarcoma	0.00146	0.00158	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Doxorubicin—sarcoma	0.00145	0.00157	CcSEcCtD
Emtricitabine—Vomiting—Mitoxantrone—sarcoma	0.00144	0.00156	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—sarcoma	0.00144	0.00156	CcSEcCtD
Emtricitabine—Rash—Mitoxantrone—sarcoma	0.00143	0.00155	CcSEcCtD
Emtricitabine—Dermatitis—Mitoxantrone—sarcoma	0.00143	0.00155	CcSEcCtD
Emtricitabine—Headache—Mitoxantrone—sarcoma	0.00142	0.00154	CcSEcCtD
Emtricitabine—Hypersensitivity—Etoposide—sarcoma	0.00139	0.0015	CcSEcCtD
Emtricitabine—Nausea—Vincristine—sarcoma	0.00138	0.0015	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—sarcoma	0.00138	0.00149	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—sarcoma	0.00138	0.00149	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—sarcoma	0.00137	0.00148	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—sarcoma	0.00136	0.00147	CcSEcCtD
Emtricitabine—Asthenia—Etoposide—sarcoma	0.00135	0.00146	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—sarcoma	0.00135	0.00146	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—sarcoma	0.00135	0.00146	CcSEcCtD
Emtricitabine—Nausea—Mitoxantrone—sarcoma	0.00135	0.00146	CcSEcCtD
Emtricitabine—Immune system disorder—Epirubicin—sarcoma	0.00134	0.00145	CcSEcCtD
Emtricitabine—Mediastinal disorder—Epirubicin—sarcoma	0.00134	0.00145	CcSEcCtD
Emtricitabine—Pruritus—Etoposide—sarcoma	0.00133	0.00144	CcSEcCtD
Emtricitabine—Mental disorder—Epirubicin—sarcoma	0.0013	0.00141	CcSEcCtD
Emtricitabine—Malnutrition—Epirubicin—sarcoma	0.0013	0.0014	CcSEcCtD
Emtricitabine—Diarrhoea—Etoposide—sarcoma	0.00129	0.0014	CcSEcCtD
Emtricitabine—Back pain—Epirubicin—sarcoma	0.00125	0.00136	CcSEcCtD
Emtricitabine—Dizziness—Etoposide—sarcoma	0.00125	0.00135	CcSEcCtD
Emtricitabine—Immune system disorder—Doxorubicin—sarcoma	0.00124	0.00135	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—sarcoma	0.00124	0.00134	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—sarcoma	0.00121	0.00131	CcSEcCtD
Emtricitabine—Vomiting—Etoposide—sarcoma	0.0012	0.0013	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—sarcoma	0.0012	0.0013	CcSEcCtD
Emtricitabine—Anaemia—Epirubicin—sarcoma	0.0012	0.0013	CcSEcCtD
Emtricitabine—Rash—Etoposide—sarcoma	0.00119	0.00129	CcSEcCtD
Emtricitabine—Dermatitis—Etoposide—sarcoma	0.00119	0.00129	CcSEcCtD
Emtricitabine—Headache—Etoposide—sarcoma	0.00118	0.00128	CcSEcCtD
Emtricitabine—Back pain—Doxorubicin—sarcoma	0.00116	0.00125	CcSEcCtD
Emtricitabine—Cough—Epirubicin—sarcoma	0.00113	0.00122	CcSEcCtD
Emtricitabine—Nausea—Etoposide—sarcoma	0.00112	0.00121	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—sarcoma	0.00111	0.0012	CcSEcCtD
Emtricitabine—Myalgia—Epirubicin—sarcoma	0.0011	0.00119	CcSEcCtD
Emtricitabine—Arthralgia—Epirubicin—sarcoma	0.0011	0.00119	CcSEcCtD
Emtricitabine—Anxiety—Epirubicin—sarcoma	0.0011	0.00119	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.0011	0.00119	CcSEcCtD
Emtricitabine—Infection—Epirubicin—sarcoma	0.00105	0.00114	CcSEcCtD
Emtricitabine—Cough—Doxorubicin—sarcoma	0.00105	0.00113	CcSEcCtD
Emtricitabine—Nervous system disorder—Epirubicin—sarcoma	0.00104	0.00112	CcSEcCtD
Emtricitabine—Thrombocytopenia—Epirubicin—sarcoma	0.00104	0.00112	CcSEcCtD
Emtricitabine—Skin disorder—Epirubicin—sarcoma	0.00103	0.00111	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—sarcoma	0.00102	0.0011	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—sarcoma	0.00102	0.0011	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—sarcoma	0.00102	0.0011	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00101	0.0011	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—sarcoma	0.000972	0.00105	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000964	0.00104	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—sarcoma	0.00096	0.00104	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—sarcoma	0.000958	0.00104	CcSEcCtD
Emtricitabine—Insomnia—Epirubicin—sarcoma	0.000957	0.00104	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—sarcoma	0.000951	0.00103	CcSEcCtD
Emtricitabine—Paraesthesia—Epirubicin—sarcoma	0.00095	0.00103	CcSEcCtD
Emtricitabine—Dyspnoea—Epirubicin—sarcoma	0.000943	0.00102	CcSEcCtD
Emtricitabine—Dyspepsia—Epirubicin—sarcoma	0.000931	0.00101	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000913	0.000988	CcSEcCtD
Emtricitabine—Fatigue—Epirubicin—sarcoma	0.000912	0.000987	CcSEcCtD
Emtricitabine—Pain—Epirubicin—sarcoma	0.000904	0.000979	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000892	0.000965	CcSEcCtD
Emtricitabine—Insomnia—Doxorubicin—sarcoma	0.000885	0.000958	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—sarcoma	0.000879	0.000951	CcSEcCtD
Emtricitabine—Dyspnoea—Doxorubicin—sarcoma	0.000872	0.000944	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Epirubicin—sarcoma	0.000865	0.000936	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—sarcoma	0.000861	0.000932	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000845	0.000914	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—sarcoma	0.000844	0.000913	CcSEcCtD
Emtricitabine—Urticaria—Epirubicin—sarcoma	0.00084	0.000909	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—sarcoma	0.000837	0.000905	CcSEcCtD
Emtricitabine—Body temperature increased—Epirubicin—sarcoma	0.000836	0.000905	CcSEcCtD
Emtricitabine—Abdominal pain—Epirubicin—sarcoma	0.000836	0.000905	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Doxorubicin—sarcoma	0.0008	0.000866	CcSEcCtD
Emtricitabine—Hypersensitivity—Epirubicin—sarcoma	0.000779	0.000843	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—sarcoma	0.000777	0.000841	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—sarcoma	0.000774	0.000837	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—sarcoma	0.000774	0.000837	CcSEcCtD
Emtricitabine—Asthenia—Epirubicin—sarcoma	0.000759	0.000821	CcSEcCtD
Emtricitabine—Pruritus—Epirubicin—sarcoma	0.000748	0.00081	CcSEcCtD
Emtricitabine—Diarrhoea—Epirubicin—sarcoma	0.000724	0.000783	CcSEcCtD
Emtricitabine—Hypersensitivity—Doxorubicin—sarcoma	0.000721	0.00078	CcSEcCtD
Emtricitabine—Asthenia—Doxorubicin—sarcoma	0.000702	0.00076	CcSEcCtD
Emtricitabine—Dizziness—Epirubicin—sarcoma	0.000699	0.000757	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—sarcoma	0.000692	0.000749	CcSEcCtD
Emtricitabine—Vomiting—Epirubicin—sarcoma	0.000672	0.000728	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—sarcoma	0.00067	0.000724	CcSEcCtD
Emtricitabine—Rash—Epirubicin—sarcoma	0.000667	0.000722	CcSEcCtD
Emtricitabine—Dermatitis—Epirubicin—sarcoma	0.000666	0.000721	CcSEcCtD
Emtricitabine—Headache—Epirubicin—sarcoma	0.000663	0.000717	CcSEcCtD
Emtricitabine—Dizziness—Doxorubicin—sarcoma	0.000647	0.0007	CcSEcCtD
Emtricitabine—Nausea—Epirubicin—sarcoma	0.000628	0.00068	CcSEcCtD
Emtricitabine—Vomiting—Doxorubicin—sarcoma	0.000622	0.000673	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—sarcoma	0.000617	0.000668	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—sarcoma	0.000616	0.000667	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—sarcoma	0.000613	0.000663	CcSEcCtD
Emtricitabine—Nausea—Doxorubicin—sarcoma	0.000581	0.000629	CcSEcCtD
